UK Markets open in 1 hr 17 mins

Orion Oyj (0M2N.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
41.40+1.65 (+4.15%)
At close: 04:45PM BST
Full screen
Previous close39.75
Open40.50
Bid0.00 x 0
Ask0.00 x 0
Day's range40.50 - 42.15
52-week range40.50 - 42.15
Volume798
Avg. volumeN/A
Market cap5.312B
Beta (5Y monthly)0.54
PE ratio (TTM)31.20
EPS (TTM)1.33
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Orion publishes Half-Year Financial Report for January–June 2022 on Friday 15 July 2022

    ORION CORPORATION PRESS RELEASE 28 June 2022 at 11.30 EEST Orion publishes Half-Year Financial Report for January–June 2022 on Friday 15 July 2022 Orion will publish Half-Year Financial Report for January–June 2022 on Friday, 15 July 2022 at approximately 12.00 noon EEST. The release and related presentation material will be available on the company’s website at www.orion.fi/en/investors after publishing. Webcast and conference call A webcast and a conference call for analysts, investors and med

  • Globe Newswire

    6,214 Orion Corporation A shares converted into B shares

    ORION CORPORATION STOCK EXCHANGE RELEASE - OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE28 JUNE 2022 at 9.30 EEST 6,214 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 6,214 A shares have been converted into 6,214 B shares. The conversion has been entered into the Trade Register on 28 June 2022. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consi

  • Globe Newswire

    Orion Acquires Inovet’s Animal Health Business

    ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION15 June 2022 at 9.30 EEST Orion Acquires Inovet’s Animal Health Business Orion Corporation (“Orion”) has entered into an agreement with Belgian private company Inovet BV (“Inovet”) to acquire its wholly owned subsidiary V.M.D. NV and all companies belonging to V.M.D. NV’s group of companies (V.M.D. NV and its subsidiary companies collectively, “VMD”). VMD is a veterinary pharmaceuticals company specialised in medicines and health produ